CNX Therapeutics
Guy Clark is currently the Chief Executive Officer at CNX Therapeutics Ltd., a speciality pharmaceutical company focused on providing essential medicines for neurological, psychiatric, and hospital emergencies. Prior to this role, Guy served as the Chief Corporate Development Officer at ADVANZ PHARMA, a global pharmaceutical company with a wide portfolio of specialty generic and legacy branded off patent medicines. Along with their experience in the pharmaceutical industry, Guy has held various roles in companies such as Spinning Fish Limited, AMCo, Creo Pharma, Diamond Pharma Services Limited, Glenmark Pharmaceuticals, IVAX Pharmaceuticals, and Pharmacia. Guy graduated with a BA (Hons) in Economics & Accounting from the University of Reading.
CNX Therapeutics
2 followers
CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines. We commercialise and distribute a portfolio of speciality brands and hospital products in Europe, in 40 countries worldwide, both directly and through strategic partnerships. Our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.